Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...

Stroke survivors often face tough choices about managing menopause symptoms. A new study from Copenhagen University Hospital–Herlev and Gentofte found that vaginal estrogen tablets were not linked to ...

Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases in serum estradiol after using vaginal estradiol tablets for 12 weeks, according to a ...

Low-dose vaginal estrogens, available in various applications such as creams, tablets, inserts, and rings, are the mainstay of GSM treatment.

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Researchers saw no link between vaginal estrogen therapy and recurrent strokes, despite concerns that the hormone is systemically absorbed. In a case-control study of female stroke survivors across ...

The US Food and Drug Administration (FDA) yesterday approved Eli Lilly’s Inluriyo (imlunestrant, 200mg tablets), an oral ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...

Using vaginal estrogen tablets was not associated with an increased risk of recurrent ischemic stroke among postmenopausal women in a registry in Denmark, according to research published in Stroke, ...